Biodesix, Inc.

Healthcare · Diagnostics & Research · United States

Last price 24.72 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 260.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to...